To analyze the outcome of 80 consecutive pediatric split liver transplants performed at the authors' center between 1994 and 2000.
Split liver transplantation (SpLT) was developed as a method of increasing the number of available liver grafts, especially for pediatric recipients. [1] [2] [3] [4] Early results were disappointing because of the high incidence of postoperative complications and inappropriate patient selection. [5] [6] [7] [8] It remains a technically demanding procedure. The in situ technique allows sharing of the organ by two different centers with equal cold ischemic times for both grafts and has been reported to have lesser rates of biliary and vascular complications than the ex situ technique. However, it is a time-consuming process, requires skilled, experienced surgeons at retrieval, and is known to increase the retrieval time by about 2 hours. 9 -11 The inherent problems with the ex situ technique have been prolonged ischemic times for the second graft and a higher incidence of biliary complications. 1, 2, 5, [12] [13] [14] This paper analyzes a single-center experience of 80 pediatric SpLTs performed over a period of 6 years, using predominantly the ex situ technique.
(80%) were performed for chronic liver disease (of which 4 were retransplants). Thirty-six patients were girls. The indications for transplantation are listed in Table 1 . Forty-two percent of patients with chronic liver failure were transplanted for extrahepatic biliary atresia, having undergone a previous Kasai portoenterostomy; non-A non-B hepatitis was the most common indication (56.2%) for transplantation in the acute liver failure group.
Seven (8.7%) were retransplants following previous reduced (n ϭ 6) and split (n ϭ 1) liver transplants. Three of these patients needed emergency retransplantation, two patients being transplanted for primary nonfunction and one for severe acute rejection. Four patients were retransplanted for chronic graft failure: two for chronic rejection, one for biliary sepsis, and one for graft atrophy in a child who had previously undergone an auxiliary partial orthotopic liver transplant for Crigler-Najjar syndrome type 1.
The age of the patients at the time of transplantation ranged from 5 days to 16 years (median 36 months) and their weight ranged from 2.5 to 64 kg (median 15 kg). Forty-nine patients (61.2%) were admitted from home for their transplant, 18 (22.5%) were already on the pediatric hepatology ward, and 13 (16.2%) were in the intensive care unit, of whom 9 were ventilated. Thirty-seven patients (46.2%) had undergone previous surgery, 27 of them having undergone a Kasai procedure.
There were 66 cadaveric donors in all, the livers from 14 of them being split for two pediatric recipients. Considering each lobe to have its individual donor, the donor data for the 80 transplanted lobes were as follows. The duration of stay in the intensive care unit ranged from 1 to 10 days (median 2 days); 43 (54%) were supported with inotropes; the age range was 6 to 49 years (median 20 years); and donor weight ranged from 20 to 95 kg (median 65 kg). All but four splitting procedures were performed ex situ. The cold ischemic time ranged from 2.3 hours (one-in situ split performed at our center) to 18.7 hours (median 10.5 hours). Four lobes were imported from other centers, three left lateral segments and one right lobe. A total of 62 livers were thus split at our center and, including imports, constituted 63 right lobes and 65 left lobes. Nine right lobes were exported and 16 were used in children in the present series. All of the remaining 38 right lobes were used for transplantation at our center in adult recipients; they had a median cold ischemic time of 16.2 hours. The export rate of right lobes was 14.5%, whereas only one (1.6%) of the left lateral segments was exported. Of the total of 124 split lobes made available by our center, only 2 (1.6%) lobes were not used; both of them were right lobes exported to other centers.
A left lateral segment was used in 63 (78.7%) of the 80 SpLTs, a left lobe in 1 (1.2%), and a right lobe in 16 (20%). In five patients the split lobe was used as an auxiliary transplant (four left lateral segments and one right lobe), the indications being Crigler-Najjar syndrome type 1 in three patients and fulminant non-A non-B in two patients. All of the left lateral segments and the left lobe were implanted using the piggyback technique. In one case, it was impossible to "fillet" the native liver off the inferior vena cava, which was therefore replaced with a segment of the donor iliac vein before implantation of the left lateral segment, as previously reported. 15 Eleven of the 16 right lobes were implanted with caval replacement and 5 using the piggyback technique. Venovenous bypass was not used in any patient.
In the majority of split procedures (75%), the main hepatic arterial trunk was allocated to the left lateral segment, although this percentage was lower when the liver was split for two pediatric recipients. An infrarenal conduit of the donor iliac artery was used in over half of the left lateral segment grafts and in four (25%) of the right lobe grafts. The biliary anastomosis was a hepaticojejunostomy to a Roux loop of jejunum in 76 patients. In four cases a ductto-duct anastomosis was performed, using a T-tube in two of these.
All patients were immunosuppressed with a triple combination therapy using cyclosporin, azathioprine, and prednisolone. The first episode of rejection was treated with three doses of methylprednisolone, 10 mg/kg body weight. Intractable acute rejection or subsequent episodes of rejection resulted in a change in immunosuppression to tacrolimus. The minimum posttransplant follow-up was 6 months and the maximum 84 months (median 42 months). Actual survival figures for the entire cohort of patients were calculated at 6 months. One-and 3-year survival figures were calculated using the Kaplan-Meier method.
RESULTS

Early Graft Function
There was no incidence of primary graft nonfunction. Primary nonfunction was defined as death or retransplantation due to graft failure within 1 week of transplantation. 16, 17 Two (2.5%) patients had poor early graft function. One of them had a left lateral segment graft for chronic liver disease; he developed a high INR in the early postoperative period and died of an intracerebral bleed on postoperative day 13, as described later. The other patient received a left lateral segment graft for acute liver failure due to non-A non-B hepatitis; he developed poor early graft function, coagulopathy, and sepsis and died on postoperative day 13. The first patient was already predisposed to intracranial bleeding, having had one in the preoperative period. The subsequent graft dysfunction contributed to the fatal bleed.
Vascular Complications
Hepatic artery thrombosis (HAT) occurred in four (5%) patients. In two, it developed in the immediate postoperative period; both patients had their arterial anastomosis revised, one with a conduit. HAT occurred at 2 and 10 months in the other two patients; they were treated conservatively as collateral circulations had developed in both cases. A further patient bled from the arterial conduit on postoperative day 5 and required revision of the arterial anastomosis. Portal venous thrombosis developed in one (1.2%) patient; this occurred on the first postoperative day and was treated by portal thrombectomy and anastomotic revision. Normal portal flow was demonstrated by a Doppler ultrasound scan in this patient 1 year later. No patient developed hepatic venous outflow obstruction. There was no graft or patient loss directly due to vascular complications.
Biliary Complications
Seven (8.7%) patients developed biliary complications, all of whom had a Roux-loop hepaticojejunostomy as the initial anastomosis: five patients had bile leaks and two developed strictures. Of the five leaks, two were from the cut surface, two were anastomotic, and one was associated with HAT and duct necrosis. Both cut surface leaks settled with percutaneous aspiration of the associated collections. The other three leaks required revision of the anastomoses, one of which went on to form a delayed stricture that has been treated by percutaneous transhepatic dilatation. In two patients the primary biliary complication was late anastomotic stricture; these were treated by revision of the anastomosis in one case and by percutaneous transhepatic dilatation in the other.
Other Complications
Two patients required a laparotomy in the immediate postoperative period for intraabdominal bleeding. One patient developed multiple colonic and Roux-loop perforations and three other patients underwent laparotomy for suspected peritonitis. Two patients developed fatal posttransplant lymphoproliferative disease (PTLD).
Retransplantation
Four patients have been retransplanted. One patient developed acute rejection resistant to high-dose steroids, tacrolimus, and mycophenolate mofetil and was retransplanted on day 20 with another split graft; two patients had to be retransplanted for chronic rejection at 3 months and 1 year, respectively; and another patient developed recurrence of acute liver failure after 15 months, presumed to be due to non-A non-B hepatitis.
Deaths and Survival Rates
All patients were followed up for a minimum of 6 months ( Table 2 ). Patient survival for the entire cohort at 6 months was 96.2%. Graft survival at 6 months was 93.7%. The Kaplan-Meier patient survival rates at 1 and 3 years were 93.5% and 88.1%, respectively (Fig. 1) . The corresponding graft survival rates were 89.7% and 86.1% (Fig. 2) .
There have been a total of nine deaths (11.2%) in the entire cohort during the follow-up period of 6 to 84 months (median 42 months). In the acute group, the patient survival rates (Kaplan-Meier) were 93.7% and 76.4% at 1 and 3 years, respectively (Fig. 3 ). There were three deaths in this group, one in the first year; this patient died on postoperative day 13. He had a left lateral segment graft for fulminant non-A non-B hepatitis and developed poor early graft func- tion, coagulopathy, and sepsis. The causes and times of death in the other two patients in the acute group were chronic rejection following retransplantation for recurrent non-A non-B hepatitis on day 686 and PTLD on day 453. In the chronic group, the corresponding 1-and 3-year survival rates were 93.6% and 90.9% (see Fig. 3 ). There were six deaths in all in this group, four in the first posttransplant year. One of the patients died of an intracranial bleed on the 13th day. This child was transplanted with a left lateral segment graft, developed poor graft function with a high INR, and underwent laparotomy for intraabdominal bleeding 6 days posttransplant. The intracranial bleed occurred a week later. The causes and times of death in the other patients were PTLD on day 168; recurrent rhabdomyosarcoma in the brain, day 193; chronic rejection, day 348; and two patients died at 3 years after transplantation, one from worsening renal failure secondary to cyclosporin toxicity, where the parents declined further treatment, and the other patient from recurrent sepsis and multiorgan failure complicated by severe portal hypertension and recurrent bleeding.
Though a detailed description of the outcome of the 38 adults receiving right lobe grafts from this series is beyond the scope of this article, it is nevertheless important to compare the results of that cohort with the present series. The 6-month survival of the 38 adult recipients was 92.1%.
The Kaplan-Meier patient survival rates at 1 and 3 years were 89.5% and 79.4%, respectively. There have been a total of seven deaths. There was no incidence of primary graft nonfunction in this cohort. Two patients died at 1 month each, both with sepsis and multiorgan failure. Five (13.2%) patients have had biliary complications; three of them were leaks and two were strictures. Two of the three leaks needed a laparotomy, while the third was managed with an internal stent. One stricture was been managed endoscopically with an internal stent, whereas the other patient needed a Roux-loop revision of the stricture, 4 years after the transplant. There was no incidence of HAT. Two (5.3%) patients had vascular complications. Both of these were arterial bleeds, one from a ruptured pseudoaneurysm 2 weeks posttransplant and the other from an erosive arterial bleed associated with a Roux-loop perforation. There were no portal or caval complications.
DISCUSSION
SpLT has had a significant impact on waiting lists for pediatric transplants. 1, 3, 4 However, initial results were disappointing because of poor patient selection and technical problems leading to graft loss. [5] [6] [7] [8] 18 Increasing experience of liver reduction and splitting techniques, coupled with an ever-widening gap between organ supply and demand, has led to increasing interest in SpLT. More recently the outcome has improved and comparisons have been made between the results of the in situ and the ex situ techniques of splitting. 9 -11,19 -21 We report our experience of SpLT in children.
Primary nonfunction following split liver transplantation has a reported incidence of up to 12.5%. 2,10,11 An incidence of 8.3% has been reported in a series of 72 in situ splits, for which cold ischemic times are expected to be lower than those with ex situ splits. 11 Prolonged cold ischemic times and warming of the graft during ex situ splitting have been found to be associated with increased susceptibility to hepatic ischemic/reperfusion injury, and it has been postulated that these factors contribute towards a higher incidence of graft dysfunction. 11, 22 The median cold ischemic time in our Split Liver Transplantation in Children series was 10.5 hours, ranging from 2.3 to 18.7 hours; there was no incidence of primary nonfunction, and all but two (2.5%) grafts showed good early function. These results would suggest that the technique of ex situ liver splitting is not necessarily a risk factor for primary nonfunction.
One of the most common causes of early graft failure and retransplantation in pediatric recipients is HAT. 23 The reported incidence in SpLT varies widely, with rates of up to 15%, 21 although a rate of 2.8% has been reported in 72 adult and pediatric in situ split transplants. 11 The rate of HAT in pediatric split transplants is in the region of 10% to 12.5%. 3, 10, 24 In our series, four (5%) children developed HAT: they had been transplanted for extrahepatic biliary atresia (two cases), sclerosing cholangitis, and familial intrahepatic cholestasis. When HAT occurred early (two patients), surgical revascularization was performed successfully. However, in both the late HAT cases, collaterals had formed that allowed the patients to be treated conservatively with satisfactory outcome. In this respect, children appear to be different to adults, in whom HAT at any stage almost invariably leads to graft loss. Arterial collateralization principally occurs via the Roux-loop, and it may be that this allows conservative management of HAT to be more successful in children than in adults.
One patient (1.2%) developed portal vein thrombosis and underwent portal thrombectomy and revision of the anastomosis with graft survival; there was no evidence of delayed portal hypertension in this patient. This complication rate compares favorably with the reported incidence of portal venous thrombosis following SpLT, which varies from 1.4% 11 to 18.8%. 24 The reported incidence of biliary complications following SpLT varies widely and in the earlier series was higher than that following whole liver transplantation. [5] [6] [7] [8] 14, 24, 25 Complication rates up to 27% have been reported. The principal problems have been cut surface leaks resulting from the splitting process and anatomical variations in superficial ducts. 2 Other factors, such as prolonged ischemic time, HAT, and chronic rejection, have also been implicated. 26 Biliary complications in pediatric recipients, however, do not seem to be significantly related to the type of biliary anastomosis or cold ischemic times. [27] [28] [29] [30] The UCLA group reported a biliary complication rate of 2.8% in their series of 72 in situ adult and pediatric splits. 11 In our series, seven (8.7%) patients developed biliary complications, five of which were bile leaks (two from the cut surface, two anastomotic, and one associated with HAT) and two of which were delayed anastomotic strictures. Biliary complications seemed to be related to technical experience: five complications occurred in the first 18 ex situ SpLTs in this series, and we have subsequently performed 58 pediatric ex situ SpLTs without biliary complications, apart from a case of duct necrosis secondary to HAT. The seventh biliary complication occurred in one of the four in situ SpLTs.
When dissecting the extrahepatic biliary tree on the back table, we pay particular attention to the origin and course of the segment 4 hepatic duct and make sure that it is appropriately ligated and divided. Similarly, we take care to identify the hepatic duct or ducts draining segment 1. We use a clamp crushing technique to divide the liver parenchyma, with meticulous attention to all vascular and biliary radicals. On-table cholangiograms have been performed in only two cases in the early stages of the program and are not performed routinely during liver splitting. Retransplantation rates following SpLT have been reported to be up to around 25%. 7, 10 The majority of retransplantations are performed for primary nonfunction and HAT. 10 Fortunately, we have had no graft loss due to either of these complications. Four (5%) of our patients have required retransplantation, one for intractable severe acute rejection, two for chronic rejection, and one for recurrence of non-A non-B hepatitis.
The reported results of SpLT have gradually been improving, from 67% survival in the early series 7, 8 to over 90% more recently 11 (Table 3 ). The early results of ex situ SpLT were disappointing, with reported patient and graft survival rates of 67% and 50%. 8 The combined European Split Registry (ex situ splits) reported patient and graft survival rates of 71% and 64%, respectively. 2 A single European center reported a 6-month survival rate in their pediatric split transplantations of 65%. 3 Our unit reported patient and graft survival rates of 90% and 88% in 1998 in our series of 41 adult and pediatric ex situ transplants. 21 More recently, the UCLA group reported overall patient and graft survival rates of 90.7% and 80.5% in their combined adult and pediatric population of 72 in situ splits. 11 Reyes et al have reported a 16.6% mortality in their pediatric SpLT program, with all of the deaths occurring in the ex situ split subgroup. 10 The Hamburg group reported a 1-year survival in pediatric splits of 84.3%. 31 The overall patient and graft survival rates in our present series are 93.5% and 89.7% at 1 year and 88.1% and 86.1% at 3 years, respectively. Nine patients have died in the follow-up period (median 42 months). In our acute group, the 1-and 3-year patient survival rates were 93.7% and 76.4%, respectively, and in the chronic group the corresponding survival rates were 93.6% and 90.9%. It has been proposed that deaths more than 3 months after orthotopic liver transplantation are probably not related to the technique or the type of transplant surgery. 6 There were two deaths within 3 months in our series, both related to poor early graft function.
The results of SpLT are encouraging. Splitting the liver in situ increases the organ retrieval time by about 2 hours, which can be a burden to the donor hospital and an inconvenience for other surgical teams at a multiorgan retrieval. We have shown that the results of ex situ splitting are comparable to those reported for the in situ technique. The excellent results reported from in situ splits, however, have been from centers with previous experience of ex situ splitting. Their results may be related not only to the technique of splitting but also to their experience in liver transplantation in general. In situ splitting, nevertheless, has inherent advantages. It allows sharing of a liver by two different centers with equal cold ischemic times and allows surface hemostasis during splitting, and as such should be the preferred technique of splitting when logistically feasible. SpLT, however, remains a demanding procedure and should be performed in centers with a wide experience of liver resections and liver reduction procedures.
